How I choose second line therapy in CLL


E-session 685001

Expert
Arnon Kater'
Hematologist
Amsterdam UMC
Amsterdam, The Netherlands
Discussant
Vadim Lesan'
University of Saarland
Saarland, Germany

27
Nov 2023

With an unrestricted grant from